|
biomedicina slovenica |
pr=Bossuyt : 10
-
Ma Christopher; Hanžel Jurij; Panaccione Remo; Sandborn William J.; D'Haens Geert; Ahuja Vijay; Atreya Raja; Bernstein Charles N.; Bossuyt Peter; Bressler Brian
CORE-IBD
2022 ►
-
Hanžel Jurij; Jairath Vipul; De Cruz Peter; Guizzetti Leonardo; Shackelton Lisa M.; Bossuyt Peter; Duijvestein Marjolijn; Dulai Parambir S.; Grossmann Johannes; Hirten Robert P.
Recommendations for standardizing clinical trial design and endoscopic assessment in postoperative Crohn's disease
2022 ►
-
Meyer Sauteur Patrick M.; Beeton Michael L; Uldum S; Bossuyt Nathalie; Vermeulen Melissa; Loens Katherine; Pereyre Sabine; Bébéar Cécile; Keše Darja; Day Jessica
Mycoplasma pneumoniae detections before and during the COVID-19 pandemic
ren A
2022 ►
-
Hanžel Jurij; Dressen Erwin; Vermeire Séverine; Löwenberg Mark; Hoentjen Frank; Bossuyt Peter; Clasquin Esmé; Baert Filip; D'Haens Geert; Mathôt Ron A
Pharmacokinetic-pharmacodynamic model of vedolizumab for targeting endoscopic remission in patients with crohn disease
2022 ►
-
Van Nieuwenhove Erika; De Langhe Ellen; Dooley James; Van Den Oord Joost; Shahrooei Mohammad; Parvaneh Nima; Ziaee Vahid; Savic Sinisa; Kačar Mark; Bossuyt Xavier
Phenotypic analysis of pyrin-associated autoinflammation with neutrophilic dermatosis patients during treatment
2021 ►
-
Meyer Sauteur Patrick M.; Beeton Michael L; Uldum S; Bossuyt Nathalie; Vermeulen Melissa; Loens Katherine; Pereyre Sabine; Bébéar Cécile; Keše Darja; Day Jessica
Mycoplasma pneumoniae prevalence before and during the COVID-19 pandemic
ren A
2021 ►
-
Fiorino Gionata; Lytras Theodore; Younge Lisa; Coenen Sofie; Chaparro Maria; Alloca Mariangela; Arnott Ian; Bossuyt Peter; Burisch Johan; De Ridder Lissy; Grosek Jan
Quality of care standards in inflammatory bowel diseases
2020 ►
-
Mollers Madelief; Barnadas Céline; Broberg Eeva; Penttinen Pasi; Teirlinck Anne C; Fischer Thea K; Popow-Kraupp Theresia; Bossuyt Nathalie; Sočan Maja; Prosenc Katarina
Current practices for respiratory syncytial virus surveillance across the EU/EEA Member States, 2017
2019 ►
-
Novak Gregor; Stevens Toer; Van Viegen Tanja; Bossuyt Peter; Štabuc Borut; Jeyarajah Jenny; Zou Guangyong; Gaemers Ingrid; McKee Trevor D.; Fu Fred; Shackelton Lisa M.
Evaluation of optimal biopsy location for assessment of histological activity, transcriptomic and immunohistochemical analyses in patients with active Crohn's disease
2019 ►
-
Drobne David; Bossuyt Peter; Breynaert Christine; Cattaert Tom; Casteele Niels Vande; Compernolle Griet; Jürgens Matthias; Ferrante Marc; Ballet Vera; Wollants Willem-Jan; Cleynen Isabelle; Van Steen Kristel; Gils Ann; Rutgeerts P.; Vermeire Séverine; Van Assche Gert
Withdrawal of immunomodulators after co-treatment does not reduce trough level of infliximab in patients with Crohn's disease
2015 ►
New search
Comments
Top of page
Institute for Biostatistics and Medical Informatics